Skip to content

Clinical trials

Observational Hypercholesterolemia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Observational Country / region: United Kingdom Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20171
20201
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Unknown status2
Completed1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Amgen1
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)1
UMC Utrecht1
Verve Therapeutics, Inc.1
Willows Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia7
Cardiovascular Diseases5
Atherosclerosis3
Diabetes Mellitus2
Dyslipidemias2
Obesity2
Acquired Immunodeficiency Syndrome1
Alzheimer Disease1
Appendicitis1
Arthritis1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.